Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.
The American Society for Therapeutic Radiology and Oncology (ASTRO) has published a new patient information brochure called "Radiation Therapy for Lung Cancer: Facts to Help Patients Understand Their Treatment."
Acusphere Inc. of Watertown, Mass., this week entered into a collaboration, license and supply agreement with Nycomed of Roskilde, Denmark for the European development and marketing rights to Acusphere's lead product candidate AI-700.
Eastman Kodak Company this week selected Rochester-based Cephire Technologies Inc., to help expand U.S. sales of Kodak's Secure Email Services beyond the healthcare market for which they were originally developed.
American Power Conversion (APC) this week introduced an enhanced line of its Symmetra Power Array scalable and redundant UPS (uninterruptible power supply).
Siemens Medical Solutions will soon join the digital mammography market, with the announcement today that it received an approvable letter from the U.S. Food and Drug Administration for the MAMMOMAT NovationDR full-field digital mammography system.
Boston will be the location of this year's American Healthcare Radiology Administrators' (AHRA) 32nd annual meeting & exposition, August 1 - 5, at the Hynes Convention Center.
RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.
Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.
A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.
